e-Article
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
Document Type
Journal
Author
Yu, Helena A.; Goto, Yasushi; Hayashi, Hidetoshi; Felip, Enriqueta; Chih-Hsin Yang, James; Reck, Martin; Yoh, Kiyotaka; Lee, Se-Hoon; Paz-Ares, Luis; Besse, Benjamin; Bironzo, Paolo; Kim, Dong-Wan; Johnson, Melissa L.; Wu, Yi-Long; John, Thomas; Kao, Steven; Kozuki, Toshiyuki; Massarelli, Erminia; Patel, Jyoti; Smit, Egbert; Reckamp, Karen L.; Dong, Qian; Shrestha, Pomy; Fan, Pang-Dian; Patel, Parul; Sporchia, Andrea; Sternberg, David W.; Sellami, Dalila; Jaenne, Pasi A.
Source
Subject
Language
English
ISSN
15277755